Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma

Abstract Metastasis is present in approximately 30% of patients diagnosed with renal cell carcinoma (RCC) and is associated with a 5-year survival rate of < 15%. Kidney injury molecule 1 (KIM-1), encoded by the HAVCR1 gene, is a proximal tubule cell-surface glycoprotein and a biomarker for early...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jasper C. Lee, Demitra M. Yotis, Ji Yun Lee, Marie A. Sarabusky, Bradly Shrum, Audrey Champagne, Ola Z. Ismail, Elena Tutunea-Fatan, Hon S. Leong, Lakshman Gunaratnam
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3782d411acd84457baceedd045480f73
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3782d411acd84457baceedd045480f73
record_format dspace
spelling oai:doaj.org-article:3782d411acd84457baceedd045480f732021-12-02T15:03:05ZKidney injury molecule-1 inhibits metastasis of renal cell carcinoma10.1038/s41598-021-90919-82045-2322https://doaj.org/article/3782d411acd84457baceedd045480f732021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90919-8https://doaj.org/toc/2045-2322Abstract Metastasis is present in approximately 30% of patients diagnosed with renal cell carcinoma (RCC) and is associated with a 5-year survival rate of < 15%. Kidney injury molecule 1 (KIM-1), encoded by the HAVCR1 gene, is a proximal tubule cell-surface glycoprotein and a biomarker for early detection of RCC, but its pathophysiological significance in RCC remains unclear. We generated human and murine RCC cell lines either expressing or lacking KIM-1, respectively, and compared their growth and metastatic properties using validated methods. Surprisingly, KIM-1 expression had no effect on cell proliferation or subcutaneous tumour growth in immune deficient (Rag1−/−) Balb/c mice, but inhibited cell invasion and formation of lung metastasis in the same model. Further, we show that the inhibitory effect of KIM-1 on metastases was observed in both immune deficient and immune competent mice. Transcriptomic profiling identified the mRNA for the pro-metastatic GTPase, Rab27b, to be downregulated significantly in KIM-1 expressing human and murine RCC cells. Finally, analysis of The Cancer Genome Atlas (TCGA) data revealed that elevated HAVCR1 mRNA expression in the two most common types of RCC, clear cell and papillary RCC, tumours correlated with significantly improved overall patient survival. Our findings reveal a novel role for KIM-1 in inhibiting metastasis of RCC and suggests that tumour-associated KIM-1 expression may be a favourable prognostic factor.Jasper C. LeeDemitra M. YotisJi Yun LeeMarie A. SarabuskyBradly ShrumAudrey ChampagneOla Z. IsmailElena Tutunea-FatanHon S. LeongLakshman GunaratnamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jasper C. Lee
Demitra M. Yotis
Ji Yun Lee
Marie A. Sarabusky
Bradly Shrum
Audrey Champagne
Ola Z. Ismail
Elena Tutunea-Fatan
Hon S. Leong
Lakshman Gunaratnam
Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
description Abstract Metastasis is present in approximately 30% of patients diagnosed with renal cell carcinoma (RCC) and is associated with a 5-year survival rate of < 15%. Kidney injury molecule 1 (KIM-1), encoded by the HAVCR1 gene, is a proximal tubule cell-surface glycoprotein and a biomarker for early detection of RCC, but its pathophysiological significance in RCC remains unclear. We generated human and murine RCC cell lines either expressing or lacking KIM-1, respectively, and compared their growth and metastatic properties using validated methods. Surprisingly, KIM-1 expression had no effect on cell proliferation or subcutaneous tumour growth in immune deficient (Rag1−/−) Balb/c mice, but inhibited cell invasion and formation of lung metastasis in the same model. Further, we show that the inhibitory effect of KIM-1 on metastases was observed in both immune deficient and immune competent mice. Transcriptomic profiling identified the mRNA for the pro-metastatic GTPase, Rab27b, to be downregulated significantly in KIM-1 expressing human and murine RCC cells. Finally, analysis of The Cancer Genome Atlas (TCGA) data revealed that elevated HAVCR1 mRNA expression in the two most common types of RCC, clear cell and papillary RCC, tumours correlated with significantly improved overall patient survival. Our findings reveal a novel role for KIM-1 in inhibiting metastasis of RCC and suggests that tumour-associated KIM-1 expression may be a favourable prognostic factor.
format article
author Jasper C. Lee
Demitra M. Yotis
Ji Yun Lee
Marie A. Sarabusky
Bradly Shrum
Audrey Champagne
Ola Z. Ismail
Elena Tutunea-Fatan
Hon S. Leong
Lakshman Gunaratnam
author_facet Jasper C. Lee
Demitra M. Yotis
Ji Yun Lee
Marie A. Sarabusky
Bradly Shrum
Audrey Champagne
Ola Z. Ismail
Elena Tutunea-Fatan
Hon S. Leong
Lakshman Gunaratnam
author_sort Jasper C. Lee
title Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
title_short Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
title_full Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
title_fullStr Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
title_full_unstemmed Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
title_sort kidney injury molecule-1 inhibits metastasis of renal cell carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3782d411acd84457baceedd045480f73
work_keys_str_mv AT jasperclee kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT demitramyotis kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT jiyunlee kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT marieasarabusky kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT bradlyshrum kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT audreychampagne kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT olazismail kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT elenatutuneafatan kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT honsleong kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
AT lakshmangunaratnam kidneyinjurymolecule1inhibitsmetastasisofrenalcellcarcinoma
_version_ 1718389070578581504